Schoenmaekers J - Search Results

1

Generation of synthetic ground glass nodules using generative adversarial networks (GANs).

Wang Z, Zhang Z, Feng Y, Hendriks LEL, Miclea RL, Gietema H, Schoenmaekers J, Dekker A, Wee L, Traverso A. Wang Z, et al. Among authors: schoenmaekers j. Eur Radiol Exp. 2022 Nov 30;6(1):59. doi: 10.1186/s41747-022-00311-y. Eur Radiol Exp. 2022. PMID: 36447082 Free PMC article.

2

Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study.

Schoenmaekers J, Hofman P, Bootsma G, Westenend M, de Booij M, Schreurs W, Houben R, De Ruysscher D, Dingemans AM, Hendriks LEL. Schoenmaekers J, et al. Eur J Cancer. 2019 Jul;115:88-96. doi: 10.1016/j.ejca.2019.04.017. Epub 2019 May 23. Eur J Cancer. 2019. PMID: 31129385

3

Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC.

Keek SA, Kayan E, Chatterjee A, Belderbos JSA, Bootsma G, van den Borne B, Dingemans AC, Gietema HA, Groen HJM, Herder J, Pitz C, Praag J, De Ruysscher D, Schoenmaekers J, Smit HJM, Stigt J, Westenend M, Zeng H, Woodruff HC, Lambin P, Hendriks L. Keek SA, et al. Among authors: schoenmaekers j. Ther Adv Med Oncol. 2022 Aug 22;14:17588359221116605. doi: 10.1177/17588359221116605. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36032350 Free PMC article.

4

Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions.

Hartgerink D, van der Heijden B, De Ruysscher D, Postma A, Ackermans L, Hoeben A, Anten M, Lambin P, Terhaag K, Jochems A, Dekker A, Schoenmaekers J, Hendriks L, Zindler J. Hartgerink D, et al. Among authors: schoenmaekers j. Front Oncol. 2018 May 9;8:154. doi: 10.3389/fonc.2018.00154. eCollection 2018. Front Oncol. 2018. PMID: 29868476 Free PMC article. Review.

5

Safety of cranial radiotherapy concurrent with tyrosine kinase inhibitors in non-small cell lung cancer patients: A systematic review.

Hendriks LE, Schoenmaekers J, Zindler JD, Eekers DB, Hoeben A, De Ruysscher DK, Dingemans AM. Hendriks LE, et al. Among authors: schoenmaekers j. Cancer Treat Rev. 2015 Jul;41(7):634-45. doi: 10.1016/j.ctrv.2015.05.005. Epub 2015 May 13. Cancer Treat Rev. 2015. PMID: 25990950 Review.

6

Unacceptable pain in oncology: The patients' perspective on reasons for absence of pain interventions.

Stoorvogel H, van Haastregt J, Theunissen M, Schoenmaekers J, Hoeben A, van den Beuken-van Everdingen M. Stoorvogel H, et al. Among authors: schoenmaekers j. Eur J Cancer Care (Engl). 2022 Sep;31(5):e13628. doi: 10.1111/ecc.13628. Epub 2022 Jun 6. Eur J Cancer Care (Engl). 2022. PMID: 35662290 Free PMC article.

7

Central nervous system metastases and oligoprogression during treatment with tyrosine kinase inhibitors in oncogene-addicted non-small cell lung cancer: how to treat and when?

Schoenmaekers JJAO, Paats MS, Dingemans AC, Hendriks LEL. Schoenmaekers JJAO, et al. Transl Lung Cancer Res. 2020 Dec;9(6):2599-2617. doi: 10.21037/tlcr-20-459. Transl Lung Cancer Res. 2020. PMID: 33489821 Free PMC article. Review.

8

Dynamics of eligibility criteria for central nervous system metastases in non-small cell lung cancer randomized clinical trials over time: A systematic review.

Schoenmaekers JJAO, Dursun S, Biesmans C, De Ruysscher DKM, Broen MPG, Remon J, Dingemans AC, Hendriks LEL. Schoenmaekers JJAO, et al. Crit Rev Oncol Hematol. 2021 Oct;166:103460. doi: 10.1016/j.critrevonc.2021.103460. Epub 2021 Aug 26. Crit Rev Oncol Hematol. 2021. PMID: 34454057 Free article. Review.

9

In-depth Analysis of Lorlatinib-related neurocognitive Adverse Events in Patients With Non-small-cell Lung Cancer.

Schoenmaekers J, Dijkstra J, van der Wekken A, Paats M, Broen M, Brandts L, Dingemans AM, Hendriks L. Schoenmaekers J, et al. Clin Lung Cancer. 2024 Mar;25(2):168-174.e1. doi: 10.1016/j.cllc.2023.12.003. Epub 2023 Dec 13. Clin Lung Cancer. 2024. PMID: 38151408 Free article.

10

Screening for Brain Metastases in Patients With NSCLC: A Qualitative Study on the Psychologic Impact of Being Diagnosed With Asymptomatic Brain Metastases.

Schoenmaekers JJAO, Bruinsma J, Wolfs C, Barberio L, Brouns A, Dingemans AC, Hendriks LEL. Schoenmaekers JJAO, et al. JTO Clin Res Rep. 2022 Aug 27;3(10):100401. doi: 10.1016/j.jtocrr.2022.100401. eCollection 2022 Oct. JTO Clin Res Rep. 2022. PMID: 36188631 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters